Heterozygous inactivating mutations in GCK, however, cause an autosomal dominant subtype of maturity onset diabetes of young (MODY), subtype glucokinase (GCK-MODY, previously termed MODY 2; OMIM #125851). Here, GCK is linked to maturity-onset diabetes of the young.